MIAT reached an agreement with Med2000 (a company with whom since long there are tight business relationship) and became the beneficial owner of rights for a new nebulizing chamber developed in Med2000 R&D labs.
This nebulizing chamber has a high scientific and innovative profile, being in a position to deliver aerosol solutions and/or suspensions with variable deposition characteristics, adapting them to the needs of different respiratory pathologies to be treated and to the specific drug to be nebulized.
